Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | SKLB-23bb |
Synonyms | |
Therapy Description |
SKLB-23bb is a selective HDAC6 inhibitor, which may result in disruption of microtubule polymerization, inhibition of the cell-cycle, and induction of apoptosis (PMID: 29610282). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SKLB-23bb | HDAC6-IN-1 | HDAC Inhibitor 45 | SKLB-23bb is a selective HDAC6 inhibitor, which may result in disruption of microtubule polymerization, inhibition of the cell-cycle, and induction of apoptosis (PMID: 29610282). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|